|
|
oviduct development
|
GO:0060066 |
3 |
0.355
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.320
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.145
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.142
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.119
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.116
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.096
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.094
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.090
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.087
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.079
|
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.077
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.075
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.073
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.073
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.073
|
|
|
|
cerebellar cortex development
|
GO:0021695 |
48 |
0.072
|
|
|
|
cervix development
|
GO:0060067 |
2 |
0.070
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.069
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.066
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.065
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.064
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.062
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.060
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.059
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.058
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.058
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.057
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.056
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.056
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.055
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.053
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.052
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.052
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.052
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.050
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.048
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.048
|
|
|
|
cellular response to parathyroid hormone stimulus
|
GO:0071374 |
2 |
0.047
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.047
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.047
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.046
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.046
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.043
|
|
|
|
cerebellum morphogenesis
|
GO:0021587 |
42 |
0.043
|
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.042
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.041
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.041
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.041
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.040
|
|
|
|
cardiac cell fate determination
|
GO:0060913 |
2 |
0.039
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.039
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.039
|
|
|
|
positive regulation of granulocyte macrophage colony stimulating factor production
|
GO:0032725 |
3 |
0.038
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.038
|
|
|
|
establishment of organ orientation
|
GO:0048561 |
1 |
0.038
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.038
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.037
|
|
|
|
meiosis i
|
GO:0007127 |
60 |
0.037
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.037
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.037
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.036
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.036
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.035
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.035
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.035
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.034
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.034
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.034
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.034
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.034
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.034
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.034
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.034
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.033
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.033
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.033
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.032
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.032
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.032
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.032
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.032
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.032
|
|
|
|
ectoderm formation
|
GO:0001705 |
3 |
0.032
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.031
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.031
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.031
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.031
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.030
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.029
|
|
|
|
maintenance of epithelial cell apical basal polarity
|
GO:0045199 |
2 |
0.029
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.029
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.029
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.029
|
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.029
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.029
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.028
|
|
|
|
spemann organizer formation at the anterior end of the primitive streak
|
GO:0060064 |
1 |
0.028
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.028
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.028
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.028
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.028
|
|
|
|
hexose transmembrane transport
|
GO:0035428 |
7 |
0.027
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.027
|
|
|
|
renal inner medulla development
|
GO:0072053 |
3 |
0.027
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.027
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.027
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.027
|
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.027
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.027
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.026
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.026
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.025
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.025
|
|
|
|
cell proliferation in forebrain
|
GO:0021846 |
30 |
0.025
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.025
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.025
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.025
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.025
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.025
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.025
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.025
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.025
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.025
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.024
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.024
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.024
|
|
|
|
motor neuron migration
|
GO:0097475 |
4 |
0.024
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.024
|
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.024
|
|
|
|
hindbrain formation
|
GO:0021576 |
1 |
0.024
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.024
|
|
|
|
visceral motor neuron differentiation
|
GO:0021524 |
3 |
0.024
|
|
|
|
wnt signaling pathway involved in forebrain neuroblast division
|
GO:0021874 |
2 |
0.024
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.023
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.023
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.023
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.023
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.023
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.023
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.023
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.023
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.023
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.023
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.023
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.023
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.023
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.023
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.023
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.023
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.023
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.022
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.022
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.022
|
|
|
|
positive regulation of mesoderm development
|
GO:2000382 |
2 |
0.022
|
|
|
|
male meiosis
|
GO:0007140 |
37 |
0.022
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.022
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.022
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.022
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.022
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.022
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.022
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.022
|
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.022
|
|
|
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.022
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.021
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.021
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.021
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.021
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.021
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.021
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.021
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.021
|
|
|
|
macrophage colony stimulating factor production
|
GO:0036301 |
1 |
0.021
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.021
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.021
|
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.021
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.021
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.021
|
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.021
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.020
|
|
|
|
midbrain hindbrain boundary maturation during brain development
|
GO:0022004 |
1 |
0.020
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.020
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.020
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.020
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.020
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.020
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.020
|
|
|
|
kidney rudiment formation
|
GO:0072003 |
3 |
0.020
|
|
|
|
establishment of endothelial blood brain barrier
|
GO:0014045 |
3 |
0.020
|
|
|
|
lateral sprouting involved in mammary gland duct morphogenesis
|
GO:0060599 |
2 |
0.020
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.020
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.020
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.020
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.019
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.019
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.019
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.019
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.019
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.019
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.019
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.019
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.019
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.019
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.019
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.019
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.019
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.019
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.019
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.019
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.018
|
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.018
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.018
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.018
|
|
|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.018
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.018
|
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.018
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.018
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.018
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.018
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.018
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.018
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.018
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.018
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.018
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.018
|
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
2 |
0.018
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.017
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.017
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.017
|
|
|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
3 |
0.017
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.017
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.017
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.017
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.017
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.017
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.017
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.017
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.017
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.017
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.017
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.017
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.017
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.017
|
|
|
|
uterine epithelium development
|
GO:0035847 |
1 |
0.017
|
|
|
|
uterus morphogenesis
|
GO:0061038 |
2 |
0.017
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.017
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.017
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.017
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.017
|
|
|
|
metanephric s shaped body morphogenesis
|
GO:0072284 |
2 |
0.017
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.017
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.017
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.017
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.017
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.017
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.017
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.017
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.017
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.017
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.016
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.016
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.016
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.016
|
|
|
|
maintenance of apical basal cell polarity
|
GO:0035090 |
3 |
0.016
|
|
|
|
rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0051123 |
3 |
0.016
|
|
|
|
dna recombination
|
GO:0006310 |
92 |
0.016
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.016
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.016
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.016
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.016
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.016
|
|
|
|
cilium morphogenesis
|
GO:0060271 |
102 |
0.016
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.016
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.016
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.016
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.016
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.016
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.016
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.016
|
|
|
|
dna templated transcriptional preinitiation complex assembly
|
GO:0070897 |
4 |
0.016
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.016
|
|
|
|
sperm egg recognition
|
GO:0035036 |
37 |
0.016
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.016
|
|
|
|
medial motor column neuron differentiation
|
GO:0021526 |
2 |
0.016
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.016
|
|
|
|
calcium independent cell cell adhesion via plasma membrane cell adhesion molecules
|
GO:0016338 |
4 |
0.016
|
|
|
|
positive regulation of anagen
|
GO:0051885 |
1 |
0.015
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.015
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.015
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.015
|
|
|
|
lung field specification
|
GO:0060424 |
3 |
0.015
|
|
|
|
establishment of anatomical structure orientation
|
GO:0048560 |
1 |
0.015
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.015
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.015
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.015
|
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.015
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.015
|
|
|
|
cell cell recognition
|
GO:0009988 |
44 |
0.015
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.015
|
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.015
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.015
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.015
|
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.015
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.015
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.015
|
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.014
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.014
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.014
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.014
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.014
|
|
|
|
cerebellar cortex formation
|
GO:0021697 |
22 |
0.014
|
|
|
|
polarity specification of proximal distal axis
|
GO:0010085 |
2 |
0.014
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.014
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.014
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.014
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.014
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.014
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.014
|
|
|
|
establishment of planar polarity involved in nephron morphogenesis
|
GO:0072046 |
1 |
0.014
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.014
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.014
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.014
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.014
|
|
|
|
negative regulation of cholesterol transport
|
GO:0032375 |
4 |
0.014
|
|
|
|
cerebellar purkinje cell layer development
|
GO:0021680 |
26 |
0.014
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.014
|
|
|
|
mesodermal to mesenchymal transition involved in gastrulation
|
GO:0060809 |
1 |
0.014
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.014
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.014
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.014
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.014
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.014
|
|
|
|
positive regulation of nuclear division
|
GO:0051785 |
27 |
0.014
|
|
|
|
non canonical wnt signaling pathway via mapk cascade
|
GO:0038030 |
3 |
0.014
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.013
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.013
|
|
|
|
regulation of interferon gamma production
|
GO:0032649 |
57 |
0.013
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.013
|
|
|
|
positive regulation of meiosis i
|
GO:0060903 |
5 |
0.013
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.013
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.013
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.013
|
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.013
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.013
|
|
|
|
zygotic determination of anterior posterior axis embryo
|
GO:0007354 |
3 |
0.013
|
|
|
|
positive regulation of macrophage colony stimulating factor production
|
GO:1901258 |
1 |
0.013
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.013
|
|
|
|
hepatic duct development
|
GO:0061011 |
1 |
0.013
|
|
|
|
regulation of lymphocyte apoptotic process
|
GO:0070228 |
41 |
0.013
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.013
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.013
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.013
|
|
|
|
positive regulation of interleukin 1 alpha production
|
GO:0032730 |
4 |
0.013
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.013
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.013
|
|
|
|
negative regulation of testosterone biosynthetic process
|
GO:2000225 |
1 |
0.013
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.013
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.013
|
|
|
|
gene silencing
|
GO:0016458 |
38 |
0.013
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.013
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.013
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.013
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.013
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.013
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.012
|
|
|
|
epithelial cell differentiation involved in kidney development
|
GO:0035850 |
23 |
0.012
|
|
|
|
fibroblast growth factor production
|
GO:0090269 |
4 |
0.012
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.012
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.012
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.012
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.012
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.012
|
|
|
|
regulation of granulocyte macrophage colony stimulating factor production
|
GO:0032645 |
3 |
0.012
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.012
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.012
|
|
|
|
positive regulation of necrotic cell death
|
GO:0010940 |
1 |
0.012
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.012
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.012
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.012
|
|
|
|
lung induction
|
GO:0060492 |
3 |
0.012
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.012
|
|
|
|
negative regulation of sterol transport
|
GO:0032372 |
4 |
0.012
|
|
|
|
eosinophil migration
|
GO:0072677 |
3 |
0.012
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.012
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.012
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.012
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.012
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.012
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.012
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.012
|
|
|
|
negative regulation of androgen biosynthetic process
|
GO:2000180 |
1 |
0.012
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.012
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.012
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.012
|
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.012
|
|
|
|
non canonical wnt signaling pathway via jnk cascade
|
GO:0038031 |
3 |
0.012
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.012
|
|
|
|
regulation of thyroid hormone generation
|
GO:2000609 |
4 |
0.012
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.012
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.012
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.012
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.012
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.012
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.012
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.012
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.012
|
|
|
|
binding of sperm to zona pellucida
|
GO:0007339 |
34 |
0.012
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.012
|
|
|
|
regulation of endodermal cell fate specification
|
GO:0042663 |
2 |
0.012
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.012
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.011
|
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
47 |
0.011
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.011
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.011
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.011
|
|
|
|
interferon gamma production
|
GO:0032609 |
67 |
0.011
|
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.011
|
|
|
|
positive regulation of transforming growth factor beta2 production
|
GO:0032915 |
2 |
0.011
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.011
|
|
|
|
bundle of his development
|
GO:0003166 |
4 |
0.011
|
|
|
|
cilium assembly
|
GO:0042384 |
81 |
0.011
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.011
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.011
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.011
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.011
|
|
|
|
nephric duct elongation
|
GO:0035849 |
1 |
0.011
|
|
|
|
rhombomere 3 development
|
GO:0021569 |
4 |
0.011
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.011
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.011
|
|
|
|
positive regulation of leukocyte apoptotic process
|
GO:2000108 |
21 |
0.011
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.011
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.011
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.011
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.011
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.011
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.011
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.011
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.011
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.011
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.011
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.011
|
|
|
|
prevention of polyspermy
|
GO:0060468 |
4 |
0.011
|
|
|
|
cerebellar cortex morphogenesis
|
GO:0021696 |
32 |
0.011
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.011
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.011
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.011
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.011
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.011
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.011
|
|
|
|
cellular response to glucose stimulus
|
GO:0071333 |
45 |
0.011
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.011
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.011
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.011
|
|
|
|
regulation of b cell tolerance induction
|
GO:0002661 |
2 |
0.011
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.011
|
|
|
|
metanephric nephron morphogenesis
|
GO:0072273 |
19 |
0.011
|
|
|
|
regulation of interleukin 1 alpha production
|
GO:0032650 |
4 |
0.011
|
|
|
|
foregut regionalization
|
GO:0060423 |
3 |
0.011
|
|
|
|
wnt signaling pathway calcium modulating pathway
|
GO:0007223 |
2 |
0.011
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.011
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.011
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.011
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
30 |
0.011
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.010
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.010
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.010
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.010
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.010
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.010
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.010
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.010
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.010
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.010
|
|
|
|
lateral motor column neuron migration
|
GO:0097477 |
3 |
0.010
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.010
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.010
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.010
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.010
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.010
|
|
|
|
regulation of t cell apoptotic process
|
GO:0070232 |
28 |
0.010
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.010
|
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.010
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.010
|
|
|
|
corpus callosum morphogenesis
|
GO:0021540 |
3 |
0.010
|
|
